| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2001PNAS...98..265Y |
| P356 | DOI | 10.1073/PNAS.98.1.265 |
| P932 | PMC publication ID | 14579 |
| P698 | PubMed publication ID | 11120884 |
| P5875 | ResearchGate publication ID | 12207577 |
| P2093 | author name string | G R Sutherland | |
| H J Eyre | |||
| G J Anderson | |||
| J Young | |||
| M Barker | |||
| G A Ramm | |||
| J. Young | |||
| B A Leggett | |||
| J R Jass | |||
| L A Simms | |||
| D R Fitzpatrick | |||
| P Huggard | |||
| K G Biden | |||
| R Karamatic | |||
| N Herath | |||
| P2860 | cites work | The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells | Q24290248 |
| The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors | Q24563124 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| CpG islands in vertebrate genomes | Q27861045 | ||
| A simple salting out procedure for extracting DNA from human nucleated cells | Q27861086 | ||
| Lessons from hereditary colorectal cancer | Q28131788 | ||
| A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells | Q28140480 | ||
| The biology of SPARC, a protein that modulates cell-matrix interactions | Q28250154 | ||
| Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis | Q28595010 | ||
| Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Q29615026 | ||
| High frequency of K-ras mutations in human colorectal hyperplastic polyps | Q33618111 | ||
| Myofibroblasts. II. Intestinal subepithelial myofibroblasts | Q33709887 | ||
| Reassessment of two apparent deletions of chromosome 16p to an ins(11;16) and a t(1;16) by chromosome painting | Q33721821 | ||
| The influence of the microenvironment on the malignant phenotype | Q33974545 | ||
| COBRA: a sensitive and quantitative DNA methylation assay | Q34630070 | ||
| Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum | Q35360361 | ||
| DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. | Q35360590 | ||
| Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. | Q35753253 | ||
| Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer | Q35788009 | ||
| Alternative genetic pathways in colorectal carcinogenesis. | Q36637607 | ||
| Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells | Q36705872 | ||
| Distinct methylation of the interferon gamma (IFN-gamma) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytes: regional IFN-gamma promoter demethylation and mRNA expression are heritable in CD44(high)CD8+ T cells | Q36851717 | ||
| DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? | Q37229443 | ||
| Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways | Q37238532 | ||
| Regulation of intestinal epithelial proliferation: a few answers, many questions | Q40883263 | ||
| Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3. | Q40954079 | ||
| Pathogenesis of hyperplastic polyps of the colon: a hypothesis based on ultrastructure and in vitro cell kinetics | Q41516985 | ||
| Morphology of sporadic colorectal cancer with DNA replication errors | Q43087650 | ||
| A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps | Q44216711 | ||
| DNA methylation differences associated with tumor tissues identified by genome scanning analysis | Q46413490 | ||
| Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. | Q48045197 | ||
| Molecular determinants of dysplasia in colorectal lesions. | Q52512023 | ||
| Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. | Q52534251 | ||
| Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. | Q53452567 | ||
| Serrated adenomatous polyposis in humans. | Q54593228 | ||
| Colorectal cancer with and without microsatellite instability involves different genes | Q73031255 | ||
| The fate of epithelial cells in the human large intestine | Q73033705 | ||
| Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis | Q73322123 | ||
| Association between CpG island methylation and microsatellite instability in colorectal cancer | Q73622839 | ||
| Phenotypic and molecular characteristics of hyperplastic polyposis | Q74127278 | ||
| Immunohistochemical analysis of pericryptal fibroblast sheath and proliferating epithelial cells in human colorectal adenomas and carcinomas with adenoma components | Q78032566 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | transmembrane protein | Q424204 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 265-270 | |
| 265-70 | |||
| P577 | publication date | 2000-12-19 | |
| 2001-01-02 | |||
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers | |
| HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers | |||
| P478 | volume | 98 |
| Q46913328 | A truncated isoform of TMEFF2 encodes a secreted protein in prostate cancer cells |
| Q24804804 | Aberrant CBFA2T3B gene promoter methylation in breast tumors |
| Q33526369 | Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer |
| Q54648210 | Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers. |
| Q39322003 | Analysis of molecular alterations in laterally spreading tumors of the colorectum |
| Q54681226 | Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. |
| Q33611481 | Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer |
| Q35761237 | Colorectal cancer: a model for epigenetic tumorigenesis |
| Q35029022 | Colorectal polyps and other precursor lesions. Need for an expanded view |
| Q35747320 | Concordant CpG island methylation in hyperplastic polyposis. |
| Q36346096 | CpG island hypermethylation in progression of esophageal and gastric cancer |
| Q33634174 | DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids. |
| Q54479306 | DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients. |
| Q33517453 | DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. |
| Q24650975 | DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers |
| Q28292507 | Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions |
| Q34615912 | Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability |
| Q43492270 | Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas |
| Q34622521 | Evolution of colorectal cancer: change of pace and change of direction. |
| Q33691683 | Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma |
| Q42321417 | Generation and characterization of Tmeff2 mutant mice |
| Q24798750 | Genetic alteration and gene expression modulation during cancer progression |
| Q35694387 | Genome-scale analysis of aberrant DNA methylation in colorectal cancer |
| Q37824622 | Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications |
| Q54342844 | High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer. |
| Q34769653 | Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers |
| Q35956892 | Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway |
| Q38767392 | Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis |
| Q40363878 | Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer. |
| Q37461935 | Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer |
| Q35596441 | Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer |
| Q36891683 | Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer |
| Q45121758 | Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients. |
| Q54497124 | Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. |
| Q78732134 | Pathogenesis of colorectal cancer |
| Q40066641 | Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17. |
| Q33188136 | Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma |
| Q36755132 | Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa |
| Q54703703 | Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. |
| Q28202238 | Repression of the TMEFF2 Promoter by c-Myc |
| Q35170428 | Role of tissue stroma in cancer cell invasion |
| Q35070896 | Serrated adenoma of the colorectum: a lesion with teeth |
| Q28740616 | TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma |
| Q40720226 | TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells |
| Q36356293 | TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer |
| Q42412048 | The Tumor Suppressive Effects of HPP1 Are Mediated Through JAK-STAT-Interferon Signaling Pathways |
| Q50928718 | The effect of TMEFF2 methylation on the tumor stage and survival outcome of clear cell renal cell carcinoma. |
| Q38985848 | The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer |
| Q33352471 | Tomoregulin internalization confers selective cytotoxicity of immunotoxins on prostate cancer cells |
| Q33850297 | Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector |
Search more.